OM
Opaleye Management’s Edgewise Therapeutics EWTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.42M | Buy |
490,000
+95,000
| +24% | +$1.25M | 1.3% | 17 |
|
|
2025
Q1 | $8.69M | Sell |
395,000
-85,000
| -18% | -$1.87M | 1.93% | 11 |
|
|
2024
Q4 | $12.8M | Sell |
480,000
-42,500
| -8% | -$1.13M | 2.24% | 10 |
|
|
2024
Q3 | $13.9M | Sell |
522,500
-57,500
| -10% | -$1.53M | 2.33% | 11 |
|
|
2024
Q2 | $10.4M | Sell |
580,000
-85,000
| -13% | -$1.53M | 2.39% | 10 |
|
|
2024
Q1 | $12.1M | Sell |
665,000
-34,000
| -5% | -$620K | 2.64% | 10 |
|
|
2023
Q4 | $7.65M | Sell |
699,000
-176,405
| -20% | -$1.93M | 2.03% | 14 |
|
|
2023
Q3 | $5.02M | Buy |
875,405
+60,405
| +7% | +$346K | 1.63% | 14 |
|
|
2023
Q2 | $6.32M | Buy |
815,000
+65,000
| +9% | +$504K | 1.51% | 17 |
|
|
2023
Q1 | $5M | Buy |
750,000
+138,600
| +23% | +$924K | 1.5% | 22 |
|
|
2022
Q4 | $5.47M | Sell |
611,400
-23,600
| -4% | -$211K | 1.9% | 16 |
|
|
2022
Q3 | $6.25M | Buy |
635,000
+183,600
| +41% | +$1.81M | 2.58% | 12 |
|
|
2022
Q2 | $3.59M | Buy |
451,400
+148,400
| +49% | +$1.18M | 1.62% | 20 |
|
|
2022
Q1 | $2.94M | Buy |
+303,000
| New | +$2.94M | 0.91% | 30 |
|